(Q34594429)

3 August 2017

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis (English)

1 reference

primary biliary cholangitis

3 August 2017

1 reference

0 references

author name string

Minoru Nakamura

1

1 reference

3 August 2017

Hisayoshi Kondo

2

1 reference

3 August 2017

Tsuyoshi Mori

3

1 reference

3 August 2017

Atsumasa Komori

4

1 reference

3 August 2017

Mutsumi Matsuyama

5

1 reference

3 August 2017

Masahiro Ito

6

1 reference

3 August 2017

Yasushi Takii

7

1 reference

3 August 2017

Makiko Koyabu

8

1 reference

3 August 2017

Terufumi Yokoyama

9

1 reference

3 August 2017

Kiyoshi Migita

10

1 reference

3 August 2017

Manabu Daikoku

11

1 reference

3 August 2017

Seigo Abiru

12

1 reference

3 August 2017

Hiroshi Yatsuhashi

13

1 reference

3 August 2017

Eiichi Takezaki

14

1 reference

3 August 2017

Naohiko Masaki

15

1 reference

3 August 2017

Kazuhiro Sugi

16

1 reference

3 August 2017

Koichi Honda

17

1 reference

3 August 2017

Hiroshi Adachi

18

1 reference

3 August 2017

Hidehiro Nishi

19

1 reference

3 August 2017

Yukio Watanabe

20

1 reference

3 August 2017

Yoko Nakamura

21

1 reference

3 August 2017

Masaaki Shimada

22

1 reference

3 August 2017

Tatsuji Komatsu

23

1 reference

3 August 2017

Akira Saito

24

1 reference

3 August 2017

Takeo Saoshiro

25

1 reference

3 August 2017

Hideharu Harada

26

1 reference

3 August 2017

Takeshi Sodeyama

27

1 reference

3 August 2017

Shigeki Hayashi

28

1 reference

3 August 2017

Akihide Masumoto

29

1 reference

3 August 2017

Takehiro Sando

30

1 reference

3 August 2017

Tetsuo Yamamoto

31

1 reference

3 August 2017

Hironori Sakai

32

1 reference

3 August 2017

Masakazu Kobayashi

33

1 reference

3 August 2017

Toyokichi Muro

34

1 reference

3 August 2017

Michiaki Koga

35

1 reference

3 August 2017

Zakera Shums

36

1 reference

3 August 2017

Gary L Norman

37

1 reference

3 August 2017

Hiromi Ishibashi

38

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2007

1 reference

3 August 2017

1 reference

3 August 2017

45

1 reference

3 August 2017

1

1 reference

3 August 2017

118-127

1 reference

Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: follow-up for up to 28 years

3 August 2017

1 reference

7 January 2021

Antimitochondrial antibodies in primary biliary cirrhosis.

1 reference

7 January 2021

Nuclear envelope protein autoantibodies in primary biliary cirrhosis

1 reference

7 January 2021

Antinuclear antibodies in primary biliary cirrhosis

1 reference

7 January 2021

Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis

1 reference

7 January 2021

Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis

1 reference

7 January 2021

Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis

1 reference

7 January 2021

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

1 reference

7 January 2021

Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study

1 reference

7 January 2021

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis

1 reference

7 January 2021

Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure?

1 reference

7 January 2021

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis.

1 reference

7 January 2021

High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities

1 reference

7 January 2021

Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

1 reference

7 January 2021

Autoantibodies as predictors of disease

1 reference

7 January 2021

Autoantibodies in diabetes

1 reference

7 January 2021

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

1 reference

7 January 2021

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

7 January 2021

Utility of serological markers in predicting the early occurrence of complications and surgery in pediatric Crohn's disease patients

1 reference

7 January 2021

Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression

1 reference

7 January 2021

Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis

1 reference

7 January 2021

Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome

1 reference

7 January 2021

Anti-centromere antibodies as a marker of Raynaud's phenomenon in pediatric rheumatologic diseases.

1 reference

7 January 2021

Anticentromere antibodies in primary biliary cirrhosis

1 reference

7 January 2021

Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients

1 reference

7 January 2021

Anti-chromatin (anti-nucleosome) autoantibodies

1 reference

7 January 2021

Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients

1 reference

7 January 2021

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group

1 reference

7 January 2021

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients

1 reference

7 January 2021

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis

1 reference

7 January 2021

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis

1 reference

7 January 2021

Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis

1 reference

7 January 2021

The cholangiopathies: disorders of biliary epithelia

1 reference

7 January 2021

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

1 reference

7 January 2021

Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2

1 reference

7 January 2021

Apoptosis, tolerance, and regulatory T cells--old wine, new wineskins

1 reference

7 January 2021

Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis

1 reference

7 January 2021

Proteasomal processing of nuclear autoantigens in systemic autoimmunity

1 reference

7 January 2021

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

1 reference

7 January 2021

Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens

1 reference

7 January 2021

Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21472

1 reference

3 August 2017

1 reference